Page last updated: 2024-10-24

2-oxoglutarate metabolic process

Definition

Target type: biologicalprocess

The chemical reactions and pathways involving oxoglutarate, the dianion of 2-oxoglutaric acid. It is a key constituent of the TCA cycle and a key intermediate in amino-acid metabolism. [ISBN:0198506732]

The 2-oxoglutarate metabolic process encompasses a series of biochemical reactions involved in the production, utilization, and degradation of 2-oxoglutarate, a key intermediate in the citric acid cycle and a central metabolite in various metabolic pathways.

2-oxoglutarate is produced in the mitochondria through the oxidative decarboxylation of isocitrate by the enzyme isocitrate dehydrogenase. It then serves as a substrate for the enzyme α-ketoglutarate dehydrogenase, which catalyzes its oxidative decarboxylation to succinyl-CoA, generating NADH and releasing carbon dioxide. This reaction is an essential step in the citric acid cycle, linking carbohydrate metabolism to the electron transport chain and ATP production.

Beyond its role in the citric acid cycle, 2-oxoglutarate plays a pivotal role in various metabolic processes, including:

- **Gluconeogenesis:** 2-oxoglutarate can be converted to glucose via the gluconeogenic pathway, providing an alternative source of glucose when carbohydrate stores are depleted.
- **Amino acid metabolism:** 2-oxoglutarate serves as an acceptor of amino groups in the transamination reactions that interconvert amino acids.
- **Nitrogen assimilation:** 2-oxoglutarate is involved in the incorporation of ammonia into organic molecules, a process crucial for nitrogen fixation and protein synthesis.
- **Synthesis of heme:** 2-oxoglutarate is required for the biosynthesis of heme, a key component of hemoglobin and other heme-containing proteins.
- **Regulation of gene expression:** 2-oxoglutarate acts as a co-substrate for certain dioxygenases, enzymes involved in the modification of DNA and histone proteins, influencing gene expression.

The metabolic fate of 2-oxoglutarate is tightly regulated by various enzymes and factors, ensuring its appropriate levels within the cell and its optimal utilization in different metabolic pathways. Disruptions in 2-oxoglutarate metabolism can lead to various metabolic disorders, including mitochondrial dysfunction, metabolic acidosis, and neurodevelopmental disorders.'
"

Proteins (5)

ProteinDefinitionTaxonomy
Kynurenine/alpha-aminoadipate aminotransferase, mitochondrialA kynurenine/alpha-aminoadipate aminotransferase, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8N5Z0]Homo sapiens (human)
Kynurenine--oxoglutarate transaminase 3A kynurenine--oxoglutarate transaminase 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q6YP21]Homo sapiens (human)
Isocitrate dehydrogenase [NADP], mitochondrialAn isocitrate dehydrogenase [NADP], mitochondrial that is encoded in the genome of human. [PRO:DNx]Homo sapiens (human)
Aspartate aminotransferase, cytoplasmicAn aspartate aminotransferase, cytoplasmic that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17174]Homo sapiens (human)
Isocitrate dehydrogenase [NADP] cytoplasmicAn isocitrate dehydrogenase [NADP] cytoplasmic that is encoded in the genome of human. [PRO:DNx]Homo sapiens (human)

Compounds (21)

CompoundDefinitionClassesRoles
ciclopiroxcyclic hydroxamic acid;
hydroxypyridone antifungal drug;
pyridone
antibacterial agent;
antiseborrheic
hydralazinehydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
azaarene;
hydrazines;
ortho-fused heteroarene;
phthalazines
antihypertensive agent;
vasodilator agent
hydralazine hydrochloridehydralazine hydrochloride : The hydrochloride salt of hydralazine; a direct-acting vasodilator that is used as an antihypertensive agent.hydrochlorideantihypertensive agent;
vasodilator agent
dihydralazineDihydralazine: 1,4-Dihydrazinophthalazine. An antihypertensive agent with actions and uses similar to those of HYDRALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p354)phthalazines
2,4-pyridinedicarboxylic acidlutidinic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 4.pyridinedicarboxylic acid
adapaleneadapalene : A naphthoic acid that is CD437 in which the phenolic hydroxy group has been converted to its methyl ether.

Adapalene: A naphthalene derivative that has specificity for RETINOIC ACID RECEPTORS. It is used as a DERMATOLOGIC AGENT for the treatment of ACNE.
adamantanes;
monocarboxylic acid;
naphthoic acid
dermatologic drug;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor;
non-steroidal anti-inflammatory drug
ziprasidoneziprasidone : A piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms.

ziprasidone: a benzisothiazoylpiperazine derivative; has combined dopamine and serotonin receptor antagonist activity; structurally related to tiospirone
1,2-benzisothiazole;
indolones;
organochlorine compound;
piperazines
antipsychotic agent;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
psychotropic drug;
serotonergic antagonist
aminopyridazineaminopyridazine: structure in first source
zuclomipheneZuclomiphene: The cis or (Z)-isomer of clomiphene.stilbenoid
oxalylglycineN-oxalylglycine : An amino dicarboxylic acid that is iminodiacetic acid with an oxo substituent. It is used as an inhibitor of alpha-ketoglutarate dependent (EC 1.14.11.*) enzymes.

oxalylglycine: structure given in first source
amino dicarboxylic acid;
N-acylglycine
EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor
mangostinalpha-mangostin : A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3 and 6, a methoxy group at position 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antioxidant, antimicrobial and antitumour activities.

mangostin: xanthone from rind of Garcinia mangostana Linn. fruit
aromatic ether;
phenols;
xanthones
antimicrobial agent;
antineoplastic agent;
antioxidant;
plant metabolite
licochalcone alicochalcone A: has both anti-inflammatory and antineoplastic activities; structure given in first source; isolated from root of Glycyrrhiza inflata; RN given refers to (E)-isomerchalcones
gamma-mangostingamma-mangostin : A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3, 6 and 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antitumour activity.phenols;
xanthones
antineoplastic agent;
plant metabolite;
protein kinase inhibitor
beta-Mangostinxanthones
nsc-287088
SYC-435SYC-435 : A cyclic hydroxamic acid that is 1-hydroxypyridin-2(1H)-one in which the hydrogens at positions 4 and 6 are substituted by methyl and benzyl groups, respectively. It is a potent inhibitor of mutant isocitrate dehydrogenase 1 (Ki values of 190 nM against R132H mutant and 120 nM against R132C mutant).benzenes;
cyclic hydroxamic acid;
pyridone
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
pf-04859989PF-04859989: a potent, brain-penetrant inhibitor of kynurenine aminotransferase II/KAT II with in vivo activity; structure in first source
agi-5198AGI-5198: inhibits isocitrate dehydrogenase 1; structure in first source
agi-6780AGI-6780: inhibits isocitrate dehydrogenases 1 and 2; structure in first source
ivosidenibivosidenib : A tertiary carboxamide resulting from the formal condensation of the carboxy group of (2S)-1-(4-cyanopyridin-2-yl)-5-oxopyrrolidine-2-carboxylic acid with the secondary amino group of (2S)-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-2-[(5-fluoropyridin-3-yl)amino]acetamide. It is approved by the FDA for the treatment of acute myeloid leukemia (AML) in patients with an isocitrate dehydrogenase-1 (IDH1) mutation.

ivosidenib: an inhibitor of isocitrate dehydrogenase 1 (IDH1) for treatment of acute myeloid leukemia (AML)
cyanopyridine;
monochlorobenzenes;
organofluorine compound;
pyrrolidin-2-ones;
secondary carboxamide;
tertiary carboxamide
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
enasidenib1,3,5-triazines;
aminopyridine;
aromatic amine;
organofluorine compound;
secondary amino compound;
tertiary alcohol
antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor